Učitavanje...
Myasthenia Gravis: Autoantibody Specificities and Their Role in MG Management
Myasthenia gravis (MG) is the most common autoimmune disorder affecting the neuromuscular junction, characterized by skeletal muscle weakness and fatigability. It is caused by autoantibodies targeting proteins of the neuromuscular junction; ~85% of MG patients have autoantibodies against the muscle...
Spremljeno u:
| Izdano u: | Front Neurol |
|---|---|
| Glavni autori: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Frontiers Media S.A.
2020
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7734299/ https://ncbi.nlm.nih.gov/pubmed/33329350 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fneur.2020.596981 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|